Mark Content Reviewer Duke Clinical Research Institute Professor of Medicine None None AstraZeneca Eli Lilly* Eli Lilly* Medtronic* Gilead Sciences Medtronic* David J. Maron Content Reviewer Vanderbilt University Medical Center Director, Vanderbilt Chest Pain Center None None AstraZeneca* None Gilead Sciences* Merck* Hani K. Najm Content Reviewer ACC Surgeons Scientific Council National Guard Health Affairs President, Saudi Heart Association None None None None L. Kristin Newby Content Reviewer Duke University Medical Center Associate Professor, Clinical Medicine AstraZeneca Daiichi-Sankyo Johnson & Johnson Philips Medical WebMD None Amylin Eli Lilly Bristol-Myers Squibb* Merck* Patrick T. O Gara Content Reviewer Brigham and Women s Hospital Director, Clinical Cardiology; Harvard Medical School Professor of Medicine None None None Lantheus Medical (Continued) Fihn et al 2014 Stable Ischemic Heart Disease Focused Update 1767 Appendix 2. Continued Peer Reviewer Representation Employment Consultant Speakers Bureau Personal Research Institutional, Organizational, or Other Financial Benefit Joseph F. Sabik Content Reviewer ACC Surgeons Scientific Council Cleveland Clinic Department Chair, Thoracic and Cardiovascular Surgery Edwards Lifesciences None Abbott Laboratories None Medtronic Edwards Lifesciences Vikas Saini Content Reviewer The Lown Institute President None None None None Frank W. Sellke Content Reviewer ACC/AHA Task Force on Practice Guidelines Brown Medical School and Lifespan Chief of Cardiothoracic Surgery None None The Medicines Company None William S. Weintraub Content Reviewer Christiana Care Health System Section Chief, Cardiology Bristol-Myers Squibb None None None Daiichi-Sankyo Eli Lilly Christopher J. 